Facebook: World Allergy Organization
Twitter: World Allergy Organization
LinkedIn: World Allergy Organization
Back to Top

Late-Breaking Abstract Submission Now Open

06September 2016

Late-Breaking Abstract Submission Now Open

Do you have high-quality, late-breaking data to share?
Be sure to submit your late-breaking abstract by 16 September 2016.

 Regular registration closes 30 September 2016.
Sign-up today for your chance to be part of an innovative environment for continual learning in allergy/immunology.

Allergy Matters at WISC 2016!


You can earn CME Credits at WISC 2016

WAO International Scientific Conference (WISC) 2016 is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS),

WISC 2016 is designated for a maximum of 21 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational session.

Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at

Where do allergy and oncology meet? - Speaker Highlights

Erika Jensen-Jarolim, MD, Chair of Comparative Medicine, Messerli Research Institute, Vienna, Austria

Why do you like attending WAO conferences?
WAO is a globally active platform of allergists where one can get the most current news in allergy. Moreover, as the Co-Editor-in-Chief of the WAO Journal, I have a great interest in following the most recent scientific developments in allergy.

What are you looking forward to at WISC 2016?
I anticipate high-end information from colleagues, and I am planning to present on brand new results.

What new findings or insights can attendees look forward to in your session?
Allergy and Cancer are complementary in terms of immune mechanisms - I am chairing an international task force on AllergoOncology that enables scientific exchange among experts in this novel field. 

The impact of tumor immunology has gained tremendous attention recently. In this era of checkpoint inhibitors, anticancer vaccines will likely make a breakthrough in the near future. I will report about the impact of Th2 immune responses, which we know so well in allergy, in malignant tissues. These include innate inflammatory cells, antibodies, and lymphocytes, which all interact and shape a Th2-biased microenvironment. Importantly, environmental factors do also contribute to the immunosuppressive environment in cancer. This is novel information for most allergists!

Attend the Workshop of Prof. Erika Jensen-Jarolim:
Tuesday, 6 December 2016 11:00 - 12:30
Workshop: Can Monoclonal Antibodies Really be Useful Weapons in Treating Allergic Diseases as they are in Cancer and Autoimmune Diseases?
Session: "AllergoOncology: The Impact of Allergy in Oncology

Recent Publication: Proof of concept study with a HER-2 mimotope anti-cancer vaccine deduced from a novel AAV-mimotope library platform.

Did you know...

Falafel is considered Israel's number one street food. Falafel balls traditionally were made out of fava beans, chickpeas or some combination of both. These days, falafel balls are usually made out of chickpeas, but you can still find other variations depending on where you buy the falafel. The falafel balls are often served in a pita or wrapped in a flat bread called taboon. The falafel balls are topped with salads, pickled vegetables, hot sauce, and drizzled with tahini-based sauces. Falafel balls may also be eaten alone as a snack or served as part of a meze tray. To learn more about food in Israel, visit the Israel Ministry of Tourism Website. (Source: Go Israel)